- 

At MESI, Ltd., we are dedicated to transforming healthcare with our original concept of predictive medical assessment. It is a great pleasure for us to announce the joining of Mr Oliver Heine as an investor and strategic advisor. With offices in Germany, France, Spain and the UK, and our products used at more than 20,000 medical practices, we are ready to enter every physician’s practice.

In the last four years, MESI has achieved a 50% year-over-year growth in the sales and installations of their main product portfolio – the MESI mTABLET. Our commitment to growth is enhanced by Mr Oliver Heine, President and CEO at HEINE Optotechnik, supporting MESI as an advisor and investor. MESI aims to benefit from Mr Heine’s extensive experience and increase the number of MESI mTABLET users to more than 100,000 over the next few years.

The MESI mTABLET is a system of diagnostic modules (a fully digital ECG, a versatile spirometer, a 1-minute ABI/TBI, a blood pressure monitor and a pulse oximeter), automated data storing in patient records, and smart clinical support tools. Together with AI analysis of the digital data created, the MESI mTABLET platform supports clinicians with predictive medical assessment, helping them discover diseases early, refer patients effectively and achieve better treatment outcomes. 

MESI is digitalizing the medical practice with the latest benefits that digital technology and AI have to offer. An all-in-one diagnostic measurement system, automatic administration and the instant recording of results are just some examples. I look forward to advising the MESI team as they strive to make the work of healthcare professionals faster and more effective.

Mr Oliver Heine, President and CEO at HEINE Optotechnik

Welcoming Mr Oliver Heine as an investor and board member is a great honour. HEINE Optotechnik has been synonymous with product quality for more than 75 years. Our common values are sustainability, customer commitment, and timely diagnostics for effective treatment. The strategic partnership with a visionary like Mr Heine is proof that our efforts have been recognised at a global level.”

Mr Jakob Susteric, co-founder and CEO at MESI


About HEINE Optotechnik:

As a global leader in the manufacture of primary diagnostic instruments with over 500 employees, HEINE Optotechnik has been a 100% family owned and managed company for more than 70 years. HEINE continues to develop and manufacture instruments at its facilities in Germany, where it combines decades-long experience and craftsmanship with the most modern manufacturing technologies. HEINE is represented in over 120 countries around the world, with subsidiaries in Australia, the US, Canada and Switzerland as well as 3,000 representatives, importers and specialist dealers.